{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:32:13Z","timestamp":1792773133287,"version":"4.5.0"},"reference-count":16,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2026,5,8]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>\n                    Precise breast cancer risk assessment (BCR) is essential for personalised prevention in women with a family history of hereditary breast and ovarian cancer (HBOC). The CanRisk model integrates monogenic variants with reproductive, lifestyle and familial factors and can be extended by Polygenic Risk Scores (PRS). We evaluated the impact of PRS-BC\n                    <jats:sub>313<\/jats:sub>\n                    in three groups: (1) healthy carriers of (likely) pathogenic variants (LP\/P), (2) affected LP\/P carriers and (3) healthy female relatives from variant-negative HBOC families.\n                  <\/jats:p>\n                  <jats:p>In healthy LP\/P carriers, median 10-year breast cancer (BC) risk remained stable, while individual estimates ranged from+25%\u2009to \u221216% compared with calculations without PRS. Among affected LP\/P carriers, contralateral BC risk shifted by+24%\u2009to \u221211%, indicating PRS effects even in high-risk individuals.<\/jats:p>\n                  <jats:p>In healthy relatives, applying the recently introduced German threshold of an 8% BC risk between ages 40 and 50 years resulted in escalation to intensified surveillance in ~6% (5\/86) (2.4\u201314%, Wilson binomial CI with Yates\u2019 correction) and de-escalation in ~1% (1\/86) (0.061\u20137.2%).<\/jats:p>\n                  <jats:p>Here, we provide new evidence of PRS clinical impact under the updated German threshold.<\/jats:p>","DOI":"10.1136\/jmg-2025-111211","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:20:41Z","timestamp":1780680041000},"page":"561-568","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["PRS-BC\n                    <sub>313<\/sub>\n                    integration for tailored breast cancer prevention in female patients and their healthy relatives"],"prefix":"10.1136","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7029-6738","authenticated-orcid":false,"given":"Rosanna H E","family":"Krakowsky","sequence":"first","affiliation":[{"name":"Institute for Human Genetics, University Hospital Leipzig, Leipzig, SN, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Drukewitz","sequence":"additional","affiliation":[{"name":"Institute for Human Genetics, University Hospital Leipzig, Leipzig, SN, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"H\u00e4ndel","sequence":"additional","affiliation":[{"name":"Institute for Human Genetics, University Hospital Leipzig, Leipzig, SN, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wiedenh\u00f6ft","sequence":"additional","affiliation":[{"name":"Institute for Human Genetics, University Hospital Leipzig, Leipzig, SN, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahriye","family":"Aktas","sequence":"additional","affiliation":[{"name":"Department of Gynecology, University Hospital Leipzig, Leipzig, SN, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4435-6610","authenticated-orcid":false,"given":"Johannes R","family":"Lemke","sequence":"additional","affiliation":[{"name":"Institute for Human Genetics, University Hospital Leipzig, Leipzig, SN, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Strehlow","sequence":"additional","affiliation":[{"name":"Institute for Human Genetics, University Hospital Leipzig, Leipzig, SN, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hentschel","sequence":"additional","affiliation":[{"name":"Institute for Human Genetics, University Hospital Leipzig, Leipzig, SN, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"2026102307200983000_63.9.561.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2018.11.002"},{"key":"2026102307200983000_63.9.561.2","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2023.103615","article-title":"Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction","volume":"73","author":"T\u00fcchler","year":"2024","journal-title":"Breast"},{"key":"2026102307200983000_63.9.561.3","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2020-2320"},{"key":"2026102307200983000_63.9.561.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-0884-4"},{"key":"2026102307200983000_63.9.561.5","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-1319"},{"key":"2026102307200983000_63.9.561.6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15153938","article-title":"Clinical Impact of Polygenic Risk Score for Breast Cancer Risk Prediction in 382 Individuals with Hereditary Breast and Ovarian Cancer Syndrome","volume":"15","author":"Stiller","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026102307200983000_63.9.561.7","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1200\/JCO.24.00285","article-title":"Breast Cancer Screening Interval: Effect on Rate of Late-Stage Disease at Diagnosis and Overall Survival","volume":"42","author":"Zuley","year":"2024","journal-title":"JCO"},{"key":"2026102307200983000_63.9.561.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2023.01.003"},{"key":"2026102307200983000_63.9.561.9","doi-asserted-by":"crossref","unstructured":"Ho PJ , Lim EH , Hartman M , et al . Breast cancer risk stratification using genetic and non-genetic risk assessment tools for 246,142 women in the UK Biobank. Genet Med 2023;25. doi:10.1016\/j.gim.2023.100917","DOI":"10.1016\/j.gim.2023.100917"},{"key":"2026102307200983000_63.9.561.10","doi-asserted-by":"crossref","DOI":"10.1038\/s41698-023-00382-z","article-title":"Development and testing of a polygenic risk score for breast cancer aggressiveness","volume":"7","author":"Shieh","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"2026102307200983000_63.9.561.11","doi-asserted-by":"crossref","first-page":"100803","DOI":"10.1016\/j.gim.2023.100803","article-title":"The clinical application of polygenic risk scores: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Abu-El-Haija","year":"2023","journal-title":"Genet Med"},{"key":"2026102307200983000_63.9.561.12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s41431-024-01647-2","article-title":"Limitations in next-generation sequencing-based genotyping of breast cancer polygenic risk score loci","volume":"32","author":"Baumann","year":"2024","journal-title":"Eur J Hum Genet"},{"key":"2026102307200983000_63.9.561.13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/curroncol32030155","article-title":"Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in Canada","volume":"32","author":"Walker","year":"2025","journal-title":"Curr Oncol"},{"key":"2026102307200983000_63.9.561.14","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jmoldx.2024.06.002","article-title":"Assessing the Risk Stratification of Breast Cancer Polygenic Risk Scores in a Brazilian Cohort","volume":"26","author":"Barreiro","year":"2024","journal-title":"J Mol Diagn"},{"key":"2026102307200983000_63.9.561.15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41431-025-02003-8","article-title":"Performance of different polygenic risk scores for breast cancer risk prediction: in-depth evaluations across large UK and Australian cohorts.","volume":"34","author":"Tanha","year":"2026","journal-title":"Eur J Hum Genet"},{"key":"2026102307200983000_63.9.561.16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7112"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2025-111211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:20:21Z","timestamp":1792765221000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2025-111211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":16,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,8,26]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/jmg-2025-111211"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2025-111211","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]}}}